Showing 1 - 8 results of 8 for search 'Yanlun Gu', query time: 0.03s
Refine Results
-
1
Identification of potential ferroptosis-associated biomarkers in rheumatoid arthritis by Xu He, Xu He, Juqi Zhang, Juqi Zhang, Juqi Zhang, Mingli Gong, Yanlun Gu, Yanlun Gu, Yanlun Gu, Bingqi Dong, Xiaocong Pang, Xiaocong Pang, Chenglong Zhang, Yimin Cui, Yimin Cui, Yimin Cui
Published 2023-07-01
Article -
2
A novel immunogenic cell death–related subtype classification and risk signature for predicting prognosis and immunotherapy efficacy in gastric cancer by Bingqi Dong, Yingchao Wu, Junling Zhang, Yanlun Gu, Yanlun Gu, Ran Xie, Ran Xie, Xu He, Xu He, Xiaocong Pang, Xiaocong Pang, Xin Wang, Yimin Cui, Yimin Cui
Published 2023-05-01
Article -
3
Risk of venous thromboembolism with janus kinase inhibitors in inflammatory immune diseases: a systematic review and meta-analysis by Juqi Zhang, Juqi Zhang, Juqi Zhang, Wenhui Li, Wenhui Li, Wenhui Li, Mingli Gong, Yanlun Gu, Yanlun Gu, Yanlun Gu, Hanxu Zhang, Hanxu Zhang, Hanxu Zhang, Bingqi Dong, Qi Guo, Qi Guo, Qi Guo, Xiaocong Pang, Xiaocong Pang, Qian Xiang, Qian Xiang, Xu He, Xu He, Yimin Cui, Yimin Cui, Yimin Cui
Published 2023-06-01
Article -
4
The challenges and opportunities of αvβ3-based therapeutics in cancer: From bench to clinical trials by Yanlun Gu, Bingqi Dong, Xu He, Zhiwei Qiu, Juqi Zhang, Mo Zhang, Haitao Liu, Xiaocong Pang, Yimin Cui
Published 2023-03-01
Article -
5
-
6
Targeting integrin pathways: mechanisms and advances in therapy by Xiaocong Pang, Xu He, Zhiwei Qiu, Hanxu Zhang, Ran Xie, Zhiyan Liu, Yanlun Gu, Nan Zhao, Qian Xiang, Yimin Cui
Published 2023-01-01
Article -
7
-
8
Targeting SLITRK4 Restrains Proliferation and Liver Metastasis in Colorectal Cancer via Regulating PI3K/AKT/NFκB Pathway and Tumor‐Associated Macrophage by Xiaojiao Sun, Junling Zhang, Bingqi Dong, Qingqing Xiong, Xin Wang, Yanlun Gu, Zhiqi Wang, Huiyu Liu, Jixin Zhang, Xu He, Hongjin Liu, Yi Zhong, Chuxiao Yi, Xiaowei Chi, Zhenming Liu, Xiaocong Pang, Yimin Cui
Published 2025-01-01
Article